Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists
- 22 January 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (4) , 1799-1809
- https://doi.org/10.1021/jm901647p
Abstract
The recent progress in crystallography of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery. To test efficiency of the structure-based approach, we performed molecular docking and virtual ligand screening (VLS) of more than 4 million commercially available “drug-like” and ‘‘lead-like’’ compounds against the A2AAR 2.6 Å resolution crystal structure. Out of 56 high ranking compounds tested in A2AAR binding assays, 23 showed affinities under 10 μM, 11 of those had sub-μM affinities and two compounds had affinities under 60 nM. The identified hits represent at least 9 different chemical scaffolds and are characterized by very high ligand efficiency (0.3−0.5 kcal/mol per heavy atom). Significant A2AAR antagonist activities were confirmed for 10 out of 13 ligands tested in functional assays. High success rate, novelty, and diversity of the chemical scaffolds and strong ligand efficiency of the A2AAR antagonists identified in this study suggest practical applicability of receptor-based VLS in GPCR drug discovery.Keywords
This publication has 55 references indexed in Scilit:
- GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complexProteins-Structure Function and Bioinformatics, 2009
- Analysis of full and partial agonists binding toβ2‐adrenergic receptor suggests a role of transmembrane helix V in agonist‐specific conformational changesJournal of Molecular Recognition, 2009
- Adenosine Receptors and Reperfusion Injury of the HeartPublished by Springer Nature ,2009
- Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac ElectrophysiologyPublished by Springer Nature ,2009
- Adenosine Receptors and CancerPublished by Springer Nature ,2009
- Introduction to Adenosine Receptors as Therapeutic TargetsPublished by Springer Nature ,2009
- Identifying conformational changes of the β2 adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulatorsJournal of Computer-Aided Molecular Design, 2009
- A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic ReceptorStructure, 2008
- Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expressionProtein Expression and Purification, 2007
- Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profilePurinergic Signalling, 2006